Fire: Created page with "{{Navbox | name = Antiarrhythmic agents | title = Antiarrhythmic agents (C01B) | state = {{{state|autocollapse}}} |listclass = hlist |group1 = Channel blockers |list1 = {{Navbox|subgroup | group1 = class I
(Na⁺ channel blockers) | list1 = {{Navbox|subgroup | group1 = class Ia (Phase 0→ and Cardiac action potenti..."

2023-11-05T08:32:14Z

Created page with "{{Navbox | name = Antiarrhythmic agents | title = Antiarrhythmic agents (C01B) | state = {{{state|autocollapse}}} |listclass = hlist |group1 = Channel blockers |list1 = {{Navbox|subgroup | group1 = class I (Na+ channel blockers) | list1 = {{Navbox|subgroup | group1 = class Ia (Phase 0→ and Cardiac action potenti..."

New page

{{Navbox
| name = Antiarrhythmic agents
| title = [[Antiarrhythmic agent]]s ([[ATC code C01#C01B|C01B]])
| state = {{{state|autocollapse}}}
|listclass = hlist

|group1 = [[Channel blocker]]s
|list1 = {{Navbox|subgroup

| group1 = [[Antiarrhythmic agent#Class I agents|class I]] ([[sodium channel blocker|Na+ channel blockers]])
| list1 = {{Navbox|subgroup

| group1 = class Ia ([[Cardiac action potential#Phase 0|Phase 0]]→ and [[Cardiac action potential#Phase 3|Phase 3]]→)
| list1 =
* [[Ajmaline]]
* [[Disopyramide]]
* [[Dihydroquinidine|Hydroquinidine]]
* [[Lorajmine]]
* [[Prajmaline]]
* [[Procainamide]]#
* [[Quinidine]]#
* [[Sparteine]]

| group2 = class Ib ([[Cardiac action potential#Phase 3|Phase 3]]←)
| list2 =
* ''[[Intravenous therapy|IV]]''
** [[Lidocaine]]#
* ''[[enteral]]''
** [[Aprindine]]
** [[Mexiletine]]
** [[Tocainide]]

| group3 = class Ic ([[Cardiac action potential#Phase 0|Phase 0]]→)
| list3 =
* [[Encainide]]‡
* [[Ethacizine]]
* [[Flecainide]]
* [[Indecainide]]‡
* [[Lorcainide]]
* [[Moracizine]]‡
* [[Propafenone]]

}}

| group3 = [[Antiarrhythmic agent#Class III agents|class III]] ([[Cardiac action potential#Phase 3|Phase 3]]→, [[potassium channel blocker|K+ channel blockers]])
| list3 =
* [[Amiodarone]]
* [[Bretylium]]
* [[Bunaftine]]
* [[Celivarone]]†
* [[Dofetilide]]
* [[Dronedarone]]
* [[E-4031]]†
* [[Ibutilide]]
* [[Nifekalant]]
* [[Sotalol]]
* [[Tedisamil]]
* [[Vernakalant]]

| group4 = [[Antiarrhythmic agent#Class IV agents|class IV]] ([[Cardiac action potential#Phase 4|Phase 4]]→, [[calcium channel blocker|Ca2+ channel blockers]])
| list4 =
* [[Diltiazem]]
* [[Verapamil]]#

}}

|group2 = [[Receptor (biochemistry)|Receptor]] [[agonist]]s and [[Receptor antagonist|antagonist]]s
|list2 = {{Navbox|subgroup

| group2 = [[Antiarrhythmic agent#Class II agents|class II]] ([[Cardiac action potential#Phase 4|Phase 4]]→, [[beta blocker|β blocker]]s)
| list2 =
* [[Nadolol]]
* [[Pindolol]]
* [[Propranolol]]
* ''cardioselective''
** [[Acebutolol]]
** [[Atenolol]]
** [[Esmolol]]
** [[Landiolol]]
** [[Metoprolol]]

| group5 = [[adenosine A1 receptor|A1 agonist]]
| list5 =
* [[Adenosine]]
* [[Benzodiazepine]]s
* [[Barbiturate]]s

| group6 = [[Muscarinic acetylcholine receptor M2|M2]]
| list6 =
* [[muscarinic antagonist]]: [[Atropine]]
* [[Disopyramide]]
* [[Quinidine]] [[muscarinic agonist]]: [[Digoxin]]

| group7 = [[Adrenergic receptor#.CE.B1 receptors|α receptors]]
| list7 =
* [[Amiodarone]]
* [[Bretylium]]
* [[Quinidine]]
* [[Verapamil]]

}}

| group8 = [[Ion transporter]]s
| list8 = {{Navbox|subgroup

| group1 = [[Na+/K+-ATPase|Na+/ K+-ATPase]]
| list1 =
* [[Digitoxin]]
* [[Digoxin]]
* [[Ouabain]]

}}

| group9 =
| list9 = {{PharmNavFootnote}}

}}<noinclude>
{{collapsible option}}
[[Category:Antiarrhythmic agents]]
[[Category:Drug templates by ATC]]
</noinclude>

Template:Antiarrhythmic agents - Revision history